Carnick & Kubik’s Allergan plc AGN Stock Holding History

Carnick & Kubik’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,136	Closed	-$636K	–	124
2015 Q1	$636K	Buy	+2,136	New	+$609K	0.53%	73

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Carnick & Kubik's AGN Position: Q2 2015 in Review

Carnick & Kubik sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 2,136 shares — an estimated $636K sold.

Carnick & Kubik first reported a position in AGN in Q1 2015 and held it in 1 quarter. The position peaked at $636K in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

Carnick & Kubik reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
Carnick & Kubik sold 2,136 Allergan plc shares in Q2 2015, an estimated $636K.
Carnick & Kubik first reported a position in Allergan plc in Q1 2015 and held it in 1 quarter.
Carnick & Kubik's Allergan plc position peaked at $636K in Q1 2015.
1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Carnick & Kubik's 13F filing for Q2 2015, filed 30 Jul 2015.